(Q45358139)

13 December 2017

title

Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea (English)

1 reference

13 December 2017

1 reference

3

Cheolwon Suh

1 reference

13 December 2017

Young Wha Koh

1

1 reference

13 December 2017

Dok Hyun Yoon

series ordinal

2

1 reference

13 December 2017

Jooryung Huh

series ordinal

4

1 reference

13 December 2017

publication date

18 April 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

91

1 reference

13 December 2017

issue

9

1 reference

13 December 2017

page(s)

1403-1412

1 reference

The biology of Hodgkin's lymphoma

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's Disease treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus in Hodgkin's disease patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Effects of aging on T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Human innate immunosenescence: causes and consequences for immunity in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

Epstein-Barr virus-associated Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1464-8

10.1007/S00277-012-1464-8

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference